Can you give us a sense of the disease burden—physiological, symptomatic, and psychological—associated with atopic dermatitis (AD) in children and adolescent patients; and to what degree is it, or can it be, truly debilitating?

Can you give us a sense of the disease burden—physiological, symptomatic, and psychological—associated with atopic dermatitis (AD) in children and adolescent patients; and to what degree is it, or can it be, truly debilitating?

CLICK HERE FOR CME CREDIT Back to Symposium

Can you give us a sense of the disease burden—physiological, symptomatic, and psychological—associated with atopic dermatitis (AD) in children and adolescent patients; and to what degree is it, or can it be, truly debilitating?

Created by

CMEducation Resources iQ&A Case-By-Case Atopic Dermatitis Medical Intelligence Zone

Presenter

Mark Lebwohl, MD

Mark Lebwohl, MD

Professor and Chairman, Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York USA